These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25572573)

  • 41. CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2.
    Wu L; Pan T; Zhou M; Chen T; Wu S; Lv X; Liu J; Yu F; Guan Y; Liu B; Zhang W; Deng X; Chen Q; Liang A; Lin Y; Wang L; Tang X; Cai W; Li L; He X; Zhang H; Ma X
    EMBO Rep; 2022 Jul; 23(7):e53855. PubMed ID: 35642598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.
    Dahabieh MS; Ooms M; Simon V; Sadowski I
    J Virol; 2013 Apr; 87(8):4716-27. PubMed ID: 23408629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic regulation of HIV-1 transcription.
    Tripathy MK; Abbas W; Herbein G
    Epigenomics; 2011 Aug; 3(4):487-502. PubMed ID: 22126207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genome-wide analysis of histone modifications in latently HIV-1 infected T cells.
    Park J; Lim CH; Ham S; Kim SS; Choi BS; Roh TY
    AIDS; 2014 Jul; 28(12):1719-28. PubMed ID: 24762674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The multifactorial nature of HIV-1 latency.
    Lassen K; Han Y; Zhou Y; Siliciano J; Siliciano RF
    Trends Mol Med; 2004 Nov; 10(11):525-31. PubMed ID: 15519278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular mechanisms of HIV-1 proviral latency.
    Bisgrove D; Lewinski M; Bushman F; Verdin E
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):805-14. PubMed ID: 16207172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
    Quivy V; De Walque S; Van Lint C
    Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic regulation of HIV latency.
    Hakre S; Chavez L; Shirakawa K; Verdin E
    Curr Opin HIV AIDS; 2011 Jan; 6(1):19-24. PubMed ID: 21242889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experimental approaches to the study of HIV-1 latency.
    Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF
    Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
    Choudhary SK; Archin NM; Margolis DM
    J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using Barcoded HIV Ensembles (B-HIVE) for Single Provirus Transcriptomics.
    Chen HC; Zorita E; Filion GJ
    Curr Protoc Mol Biol; 2018 Apr; 122(1):e56. PubMed ID: 29851299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chromatin Regulation and the Histone Code in HIV Latency
.
    Turner AW; Margolis DM
    Yale J Biol Med; 2017 Jun; 90(2):229-243. PubMed ID: 28656010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycomb repressive complex 2 inhibitors: emerging epigenetic modulators.
    Danishuddin ; Subbarao N; Faheem M; Khan SN
    Drug Discov Today; 2019 Jan; 24(1):179-188. PubMed ID: 30031878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency.
    Irwan ID; Bogerd HP; Cullen BR
    Nat Microbiol; 2022 Dec; 7(12):2101-2113. PubMed ID: 36376394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The sounds of silencing: dynamic epigenetic control of HIV latency.
    Nguyen K; Karn J
    Curr Opin HIV AIDS; 2024 May; 19(3):102-109. PubMed ID: 38547337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic crosstalk in chronic infection with HIV-1.
    Lange UC; Verdikt R; Ait-Ammar A; Van Lint C
    Semin Immunopathol; 2020 Apr; 42(2):187-200. PubMed ID: 32047948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Position effects influence HIV latency reversal.
    Chen HC; Martinez JP; Zorita E; Meyerhans A; Filion GJ
    Nat Struct Mol Biol; 2017 Jan; 24(1):47-54. PubMed ID: 27870832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromatin, gene silencing and HIV latency.
    Mok HP; Lever AM
    Genome Biol; 2007; 8(11):228. PubMed ID: 18036274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The rise of epigenetic targets for the development of novel antivirals.
    Kristie TM
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1359-61. PubMed ID: 23253311
    [No Abstract]   [Full Text] [Related]  

  • 60. Varying virulence: epigenetic control of expression noise and disease processes.
    Miller-Jensen K; Dey SS; Schaffer DV; Arkin AP
    Trends Biotechnol; 2011 Oct; 29(10):517-25. PubMed ID: 21700350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.